Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about Maternal Obesity 10 Conferences, 4 Relavant Journals and 200 open access articles are presently dedicated exclusively to Maternal Obesity and about 8 articles are being published on Maternal Obesity. Maternal Obesity or Parental obesity (defined as obesity during pregnancy) increases health risks for both the mother and child during and after pregnancy. Maternal Obesity has a significant impact on maternal metabolism and offspring development.
Insulin resistance, glucose homeostasis fat oxidation and amino acid synthesisare all disrupted by maternal obesity and contribute to adverse outcomes. Modification of lifestyle is an effective intervention strategy for improvement of maternal metabolism and the prevention of adverse outcomes.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Maternal Obesity conference provides the scope for opportunities to learn progressed by international scientists and academicians. Maternal Obesity is also sometimes also called as Parental obesity which is the science concerned that deals with the causes, prevention, and treatment of maternal obesity. Maternal Obesity is associated with greater risk of pregnancy complications. Additionally, children born to overweight and diabetic mothers are often large for gestational age, and at increased risk for developing metabolic syndrome later in life. It is thought that the intrauterine environment might be central to these observed outcomes, however, the particular characteristics of this environment remain elusive.
Maternal Obesity and consumption of high-fat diet can influence fetal development and growth. Placental inflammation leads to molecular alterations in different tissues in the off spring. Hypothalamic tissues can show early changes in the expression of neuropeptides, which contribute to damages in metabolic control and energy homeostasis. Inflammation of the placenta can affect orexigenic/anorexigenic neuropeptides, reward system, and energy expenditure, which in turn contribute to obesity and diabetes in the offspring. These changes can be caused by epigenetic mechanisms and can be passed on from the mother to the offspring .
Maternal Obesity conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of:
It also provides the platform for researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Maternal Obesity.
Maternal obesity is defined as obesity during pregnancy which increases health risks for both the mother and child during and after pregnancy. During pregnancy weight gain should typically fall between 11-20 pounds in order to improve outcomes for both mother and child. Increased rates of hypertension, diabetes, respiratory complications, and infections are prevalent in cases of maternal obesity and can have detrimental effects on pregnancy outcomes. Maternal obesity is an extremely strong risk factor for gestational diabetes.
Maternal obesity increases the risk for the offspring in developing obesity and altering body composition in child- and adulthood and, additionally, it also has an impact on the offspring's cardiometabolic health with dysregulation of metabolism including glucose/insulin homoeostasis, and development of hypertension and vascular dysfunction. Potential mechanisms include effects on the development and function of adipose tissue, pancreas, muscle, liver, the vasculature and the brain.
The risks related to obesity during pregnancy for the mother are:
• maternal death or severe morbidity
• cardiac disease
• spontaneous first trimester and recurrent miscarriage
• pre-eclampsia
• gestational diabetes
• thromboembolism
• post-caesarean wound infection
• infection from other causes
• postpartum haemorrhage
• low breastfeeding rates
Research has found that obese mothers who lose weight (at least 10 pounds) in-between pregnancies reduce the risk of gestational diabetes during their next pregnancy, whereas mothers who gain weight actually increase their risk.
Market Analysis:
Prevalence rates (PR) of overweight and obesity among the children were 15.6% and 12.9%, respectively. Among the subset of breastfed children, factors associated with the outcome were maternal overweight and/or obesity (PR 1.92; 95% confidence interval “95% CI” 1.15–3.24) and lower income (PR 0.50; 95% CI 0.29–0.85). Among children who had not been breastfed or had been breastfed for shorter periods (less than 12 months), predictors were mothers with lower levels of education (PR 0.39; 95% CI 0.19–0.78), working mothers (PR 1.83; 95% CI 1.05–3.21), caesarean delivery (PR 1.98; 95% CI 1.14 – 3.50) and maternal obesity (PR 3.05; 95% CI 1.81 – 5.25).
List of Best International Conferences:
1 ) 5th Exhibition on Obesity and Weight Management conference
December 05-07, 2016 Philadelphia, USA
2) 4th Euro Obesity & Endocrinology Specialists Annual Meeting
March 28-30, 2016 Valencia, Spain
3) World Congress on Obesity
August 08-10, 2016 Toronto, Canada
4) 2nd Sports Medicine and Fitness Conference
April 18-20, 2016 Dubai, UAE
5) 2nd Euro Health Care and Fitness Summit
September 26-28, 2016 London, UK
6) 6th Exhibition on Diet and Nutrition conference
August 18-20, 2016 London, UK
7) World Congress on Public Health & Nutrition
March 10-12, 2016 Madrid, Spain, 2016
8) 6th Endocrinology conference
November 28-30, 2016 Baltimore, USA
9) 11th Exhibition on Targeting Diabetes and Novel Therapeutics
October 17-19, 2016 Kuala Lumpur, Malaysia.
10) Metabolic Syndromes
October 20-22, 2016 Dubai, UAE
11)3rd Global Experts Meeting on Weight Loss and Medicare Expo
September 19-21, 2016 Vienna, Austria.
12) 9th Global Diabetes Summit and Medicare Expo
November 14-16, 2016 Dubai, UAE
13) ICO 2016 : 18th International Conference on Obesity London
May23-24, 2016, United Kingdom
14) The 2016 Obesity Summit
12-14th April 2016, London
15) Emirates Obesity and Metabolic Surgery Interest Group
12 – 14 December 2015, Raffles Hotel Dubai, UAE
16)The XIII International Conference on Obesity
May 1-4, 2016 Vancouver, BC, Canada
17)23rd European Congress on Obesity
Gothenburg, Sweden, June 1–4, 2016
18)Obesity Week 2016
October 31–November 5, 2016, New Orleans, Louisiana, USA
19)Hot Topic Conference: Obesity and Pregnancy
29 - 30 October 2015, London, UK
20)MASO 2015 Scientific Conference on Obesity
Seri Pacific Hotel,28-29 October, 2015, Kuala Lumpur
World Obesity
The British Obesity and Metabolic Surgery Society (BOMSS)
EASO – European Association for the study of Obesity
British Obesity Society
American Society for Bariatric Surgeons
IDEA Health & Fitness Association
Aston Aerial Fitness Society
National Obesity Forum
NHLBI obesity research
Office of Dietary Supplements (ODS)
JASSO Japan Society for the Study of Obesity
American Heart Association
The Nutrition Society (NS)
Phillipine Association for the study of Obesity
The American Society for Metabolic and Bariatric Surgery (ASMBS)
European Society of Endocrinology and Obesity
American Sports and Fitness Asociation (ASFA)
European Fitness Association (EFA)
Aerobics and Fitness Association of America (AFAA)
The European Health and Fitness Association (EHFA)
American Association For Clinical Endocrinologists (AACE)
Companies
Fierce Pharma
Zafgen
Nasdaq
Citius Pharmaceuticals
Citius Pharma
Exome
Ipsos
Gen Pharma
M Pharmaceutical Inc.
Neo Pharma
Getz Pharma
Arena Pharmaceuticals Inc.
Orexigen Therapeutics, Inc.
M Pharmaceutical
Bio Pharma
This page will be updated regularly.
This page was last updated on December 23, 2024
